Chemed Reports Second-Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Chemed Corporation (CHE) Tops Q2 EPS by 66c, Offers FY Guidance
July 29, 2020 4:42 PM EDTChemed Corporation (NYSE: CHE) reported Q2 EPS of $4.41, $0.66 better than the analyst estimate of $3.75. Revenue for the quarter came in at $502 million versus the consensus estimate of $522.89 million.
GUIDANCE:
Chemed Corporation sees FY2020 EPS of $16.20-$16.40, versus the consensus of $16.13.
Historically, Chemed earnings guidance has been developed using previous years key operating metrics which are then modeled and projected out for the calendar year. Critical within these projections is the understanding of traditional patterned correlations among key operating metrics. Once we complete this phase of our projected... More
